27893864|t|Cost-Effectiveness of the ' One4All ' HIV Linkage Intervention in Guangxi Zhuang Autonomous Region, China
27893864|a|In Guangxi Zhuang Autonomous Region, China, an estimated 80% of newly-identified antiretroviral therapy (ART)-eligible patients are not engaged in ART. Delayed ART uptake ultimately translates into high rates of HIV morbidity, mortality, and transmission. To enhance HIV testing receipt and subsequent treatment uptake in Guangxi, the Chinese Center for Disease Control and Prevention (CDC) executed a cluster-randomized trial to assess the effectiveness and cost-effectiveness of a streamlined HIV testing algorithm (the One4All intervention) in 12 county-level hospitals. To determine the incremental cost-effectiveness of the One4All intervention delivered at county hospitals in Guangxi, China, compared to the current standard of care (SOC). Health System. 1-, 5-and 25-years. We adapted a dynamic, compartmental HIV transmission model to simulate HIV transmission and progression in Guangxi, China and identify the economic impact and health benefits of implementing the One4All intervention in all Guangxi hospitals. The One4All intervention algorithm entails rapid point-of-care HIV screening, CD4 and viral load testing of individuals presenting for HIV screening, with same-day results and linkage to counselling. We populated the model with data from the One4All trial (CTN-0056), China CDC HIV registry and published reports. Model outcomes were HIV incidence, mortality, costs, quality-adjusted life years (QALYs), and the incremental cost-effectiveness ratio (ICER) of the One4All intervention compared to SOC. The One4All testing intervention was more costly than SOC (CNY 2,182 vs. CNY 846), but facilitated earlier ART access, resulting in delayed disease progression and mortality. Over a 25-year time horizon, we estimated that introducing One4All in Guangxi would result in 802 averted HIV cases and 1629 averted deaths at an ICER of CNY 11,678 per QALY gained. Sensitivity analysis revealed that One4All remained cost-effective at even minimal levels of effectiveness. Results were robust to changes to a range of parameters characterizing the HIV epidemic over time. The One4All HIV testing strategy was highly cost-effective by WHO standards, and should be prioritized for widespread implementation in Guangxi, China. Integrating the intervention within a broader combination prevention strategy would enhance the public health response to HIV / AIDS in Guangxi.
27893864	28	35	One4All	T058	UMLS:C1321876
27893864	38	41	HIV	T038	UMLS:C0019693
27893864	50	62	Intervention	T058	UMLS:C0184661
27893864	66	98	Guangxi Zhuang Autonomous Region	T082	UMLS:C0017446
27893864	100	105	China	T082	UMLS:C0008115
27893864	109	141	Guangxi Zhuang Autonomous Region	T082	UMLS:C0017446
27893864	143	148	China	T082	UMLS:C0008115
27893864	187	209	antiretroviral therapy	T058	UMLS:C1963724
27893864	211	214	ART	T058	UMLS:C1963724
27893864	253	256	ART	T058	UMLS:C1963724
27893864	266	269	ART	T058	UMLS:C1963724
27893864	318	321	HIV	T038	UMLS:C0019693
27893864	348	360	transmission	T038	UMLS:C0242781
27893864	373	376	HIV	T038	UMLS:C0019693
27893864	408	417	treatment	T058	UMLS:C0087111
27893864	428	435	Guangxi	T082	UMLS:C0017446
27893864	441	490	Chinese Center for Disease Control and Prevention	T092	UMLS:C1274109
27893864	492	495	CDC	T092	UMLS:C1274109
27893864	508	532	cluster-randomized trial	T062	UMLS:C0206034
27893864	601	604	HIV	T038	UMLS:C0019693
27893864	628	635	One4All	T058	UMLS:C1321876
27893864	636	648	intervention	T058	UMLS:C0184661
27893864	669	678	hospitals	T092	UMLS:C0019994
27893864	735	742	One4All	T058	UMLS:C1321876
27893864	743	755	intervention	T058	UMLS:C0184661
27893864	776	785	hospitals	T092	UMLS:C0019994
27893864	789	796	Guangxi	T082	UMLS:C0017446
27893864	798	803	China	T082	UMLS:C0008115
27893864	829	845	standard of care	T058	UMLS:C2936643
27893864	847	850	SOC	T058	UMLS:C2936643
27893864	924	927	HIV	T038	UMLS:C0019693
27893864	928	940	transmission	T038	UMLS:C0242781
27893864	959	962	HIV	T038	UMLS:C0019693
27893864	963	975	transmission	T038	UMLS:C0242781
27893864	980	991	progression	T038	UMLS:C0242656
27893864	995	1002	Guangxi	T082	UMLS:C0017446
27893864	1004	1009	China	T082	UMLS:C0008115
27893864	1083	1090	One4All	T058	UMLS:C1321876
27893864	1091	1103	intervention	T058	UMLS:C0184661
27893864	1111	1118	Guangxi	T082	UMLS:C0017446
27893864	1119	1128	hospitals	T092	UMLS:C0019994
27893864	1134	1141	One4All	T058	UMLS:C1321876
27893864	1142	1154	intervention	T058	UMLS:C0184661
27893864	1193	1196	HIV	T038	UMLS:C0019693
27893864	1197	1206	screening	T058	UMLS:C1710031
27893864	1208	1211	CD4	T103	UMLS:C0003323
27893864	1216	1226	viral load	T058	UMLS:C1168369
27893864	1238	1249	individuals	T098	UMLS:C0237401
27893864	1265	1268	HIV	T038	UMLS:C0019693
27893864	1269	1278	screening	T058	UMLS:C1710031
27893864	1317	1328	counselling	T058	UMLS:C0010210
27893864	1372	1385	One4All trial	T058	UMLS:C1321876
27893864	1387	1395	CTN-0056	T058	UMLS:C1321876
27893864	1398	1403	China	T082	UMLS:C0008115
27893864	1404	1407	CDC	T092	UMLS:C1274109
27893864	1408	1411	HIV	T038	UMLS:C0019693
27893864	1425	1442	published reports	T170	UMLS:C0684224
27893864	1450	1458	outcomes	T062	UMLS:C0086750
27893864	1464	1467	HIV	T038	UMLS:C0019693
27893864	1593	1613	One4All intervention	T058	UMLS:C0184661
27893864	1626	1629	SOC	T058	UMLS:C2936643
27893864	1635	1663	One4All testing intervention	T058	UMLS:C0184661
27893864	1685	1688	SOC	T058	UMLS:C2936643
27893864	1738	1741	ART	T058	UMLS:C1963724
27893864	1771	1790	disease progression	T038	UMLS:C0242656
27893864	1865	1872	One4All	T058	UMLS:C1321876
27893864	1876	1883	Guangxi	T082	UMLS:C0017446
27893864	1912	1915	HIV	T038	UMLS:C0019693
27893864	1939	1945	deaths	T038	UMLS:C0011065
27893864	2000	2008	analysis	T062	UMLS:C0936012
27893864	2023	2030	One4All	T058	UMLS:C1321876
27893864	2171	2174	HIV	T038	UMLS:C0019693
27893864	2199	2206	One4All	T058	UMLS:C1321876
27893864	2207	2210	HIV	T038	UMLS:C0019693
27893864	2257	2260	WHO	T092	UMLS:C0043237
27893864	2331	2338	Guangxi	T082	UMLS:C0017446
27893864	2340	2345	China	T082	UMLS:C0008115
27893864	2363	2375	intervention	T058	UMLS:C0184661
27893864	2443	2465	public health response	T033	UMLS:C1704632
27893864	2469	2472	HIV	T038	UMLS:C0019693
27893864	2475	2479	AIDS	T038	UMLS:C0001175
27893864	2483	2490	Guangxi	T082	UMLS:C0017446